Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)
China · Delayed Price · Currency is CNY 2.370
+0.020 (0.85%)
Jul 31, 2026, 3:00 PM CST
SHA:603077 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6,816 | 6,699 | 6,999 | 3,064 | 4,591 | 1,711 |
Trading Asset Securities | - | - | - | - | - | 56.89 |
Cash & Short-Term Investments | 6,816 | 6,699 | 6,999 | 3,064 | 4,591 | 1,768 |
Cash Growth | -4.28% | -4.29% | 128.43% | -33.26% | 159.70% | 109.01% |
Accounts Receivable | 1,027 | 1,010 | 2,043 | 2,049 | 2,568 | 1,656 |
Other Receivables | 39.41 | 24.07 | 30.07 | 34.35 | 23.09 | 19.55 |
Receivables | 1,066 | 1,034 | 2,073 | 2,084 | 2,591 | 1,675 |
Inventory | 4,211 | 3,909 | 4,545 | 4,403 | 2,076 | 912.2 |
Other Current Assets | 376.74 | 381.62 | 385.99 | 303.87 | 460.25 | 287.84 |
Total Current Assets | 12,470 | 12,024 | 14,003 | 9,855 | 9,719 | 4,643 |
Property, Plant & Equipment | 9,436 | 9,541 | 9,952 | 9,684 | 9,483 | 8,295 |
Long-Term Investments | 885.33 | 892.36 | 857.45 | 667.27 | 677.37 | 661.99 |
Goodwill | 1,778 | 1,778 | 1,838 | 1,838 | 1,838 | 1,904 |
Other Intangible Assets | 2,837 | 2,850 | 2,389 | 2,200 | 2,143 | 1,967 |
Long-Term Deferred Tax Assets | 133.93 | 145.9 | 127.23 | 50.38 | 110.3 | 25.83 |
Long-Term Deferred Charges | 286.54 | 232.38 | 174.48 | 105.46 | 34.01 | 7.29 |
Other Long-Term Assets | 892.58 | 745.54 | 308.09 | 142.16 | 97.84 | 417.19 |
Total Assets | 28,719 | 28,209 | 29,650 | 24,542 | 24,103 | 17,922 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 801.48 | 930.52 | 2,108 | 1,877 | 1,877 | 1,156 |
Accrued Expenses | 53.15 | 96.52 | 76.21 | 103.01 | 91.37 | 126.24 |
Short-Term Debt | 1,329 | 2,308 | 2,353 | 1,168 | 1,222 | 1,171 |
Current Portion of Long-Term Debt | 781.58 | 260.08 | 745.33 | 342.32 | 164 | 95 |
Current Portion of Leases | - | 14.13 | 5.97 | 2.44 | 2.44 | - |
Current Income Taxes Payable | 55.68 | 13.77 | 14.87 | 55.01 | 95.71 | 140.79 |
Current Unearned Revenue | 194.52 | 139.23 | 49.55 | 96.6 | 235.07 | 371.54 |
Other Current Liabilities | 20.02 | 21.88 | 21.7 | 25.43 | 46.5 | 62.07 |
Total Current Liabilities | 3,235 | 3,784 | 5,375 | 3,670 | 3,734 | 3,123 |
Long-Term Debt | 6,943 | 6,109 | 4,936 | 431.17 | 408.48 | 68.09 |
Long-Term Leases | 20.59 | 21.96 | 14.52 | 24.94 | 21.54 | 37.06 |
Long-Term Unearned Revenue | 144.76 | 145.15 | 130.17 | 75.25 | 79.03 | 16.79 |
Long-Term Deferred Tax Liabilities | 181.62 | 173.78 | 187.92 | 122.75 | 96.02 | 39.99 |
Other Long-Term Liabilities | 12.52 | 16.15 | - | - | - | - |
Total Liabilities | 10,537 | 10,251 | 10,643 | 4,324 | 4,339 | 3,285 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 8,832 | 8,832 | 8,831 | 8,831 | 8,831 | 8,831 |
Additional Paid-In Capital | 980.93 | 950.18 | 1,035 | 1,125 | 1,095 | 470.46 |
Retained Earnings | 9,720 | 9,546 | 10,078 | 10,204 | 9,313 | 5,642 |
Treasury Stock | -1,749 | -1,790 | -1,697 | -650.37 | -150 | -700 |
Comprehensive Income & Other | 318.64 | 338.56 | 379.15 | 66.4 | 29.45 | 1.9 |
Total Common Equity | 18,102 | 17,877 | 18,626 | 19,575 | 19,118 | 14,245 |
Minority Interest | 79.38 | 81.91 | 380.13 | 643.04 | 644.86 | 391.84 |
Shareholders' Equity | 18,182 | 17,959 | 19,007 | 20,218 | 19,763 | 14,637 |
Total Liabilities & Equity | 28,719 | 28,209 | 29,650 | 24,542 | 24,103 | 17,922 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 9,074 | 8,714 | 8,055 | 1,969 | 1,818 | 1,372 |
Net Cash (Debt) | -2,258 | -2,015 | -1,056 | 1,096 | 2,773 | 396.4 |
Net Cash Growth | - | - | - | -60.49% | 599.57% | - |
Net Cash Per Share | -0.28 | -0.25 | -0.12 | 0.13 | 0.32 | 0.05 |
Filing Date Shares Outstanding | 7,997 | 7,974 | 8,022 | 8,512 | 8,725 | 8,394 |
Total Common Shares Outstanding | 7,997 | 7,974 | 8,022 | 8,512 | 8,725 | 8,394 |
Working Capital | 9,235 | 8,240 | 8,629 | 6,185 | 5,985 | 1,520 |
Book Value Per Share | 2.26 | 2.24 | 2.32 | 2.30 | 2.19 | 1.70 |
Tangible Book Value | 13,487 | 13,249 | 14,399 | 15,537 | 15,137 | 10,374 |
Tangible Book Value Per Share | 1.69 | 1.66 | 1.79 | 1.83 | 1.73 | 1.24 |
Buildings | - | 4,134 | 3,766 | 3,564 | 2,856 | - |
Machinery | - | 11,638 | 11,303 | 11,677 | 10,357 | - |
Construction In Progress | - | 2,136 | 2,354 | 1,174 | 1,885 | - |